Get 20% lifetime commission for referring investors to digrin.com
here.
TRACON Pharmaceuticals, Inc. (TCON) Financials
Stock symbol TCON is outdated, potentially delisted? Maybe it is available on other exchange?
TCON Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2024 | 7.4 million | 10.5 million |
| March 31, 2024 | 9.4 million | 11.1 million |
| Dec. 31, 2023 | 10.1 million | 10.9 million |
| Sept. 30, 2023 | 9.4 million | 12.5 million |
TCON Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2024 | -2.8 million | 339000 |
| March 31, 2024 | -2.5 million | 383000 |
| Dec. 31, 2023 | -522000 | 490000 |
| Sept. 30, 2023 | 15.1 million | 493000 |
TCON Net Income
No data available :(
TCON Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2024 | 6.3 million | - | - |
| March 31, 2024 | 7.9 million | - | - |
| Dec. 31, 2023 | 8.6 million | 732000 | 236000 |
| Sept. 30, 2023 | 7.8 million | 700000 | 1.0 million |
TCON Shares Outstanding
TCON Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2024 | - | 1.4 million | 1.6 million | - |
| March 31, 2024 | - | 1.9 million | 1.4 million | - |
| Dec. 31, 2023 | - | 1.5 million | 1.1 million | - |
| Sept. 30, 2023 | - | 2.3 million | 1.3 million | - |
TCON Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2024 | 55000 | - |
| March 31, 2024 | 100000 | 4000 |
| Dec. 31, 2023 | 3.0 million | 3000 |
| Sept. 30, 2023 | - | 4000 |
TCON
Price: $0.03
52 week price:
Earnings Per Share: 5.93 USD
P/E Ratio: 0.01
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 47100
Ebitda: 1.4 millionMarket Capitalization: 109725